医学
托珠单抗
葡萄膜炎
眼科
皮肤病科
内科学
疾病
作者
Saleema Kherani,Akhila Alapati,Tedi Begaj,Steven A. Atlas,Anjum F. Koreishi,Timothy M. Janetos,Lisa Faia,Debra A. Goldstein
标识
DOI：10.1016/j.ophtha.2024.10.010
摘要
This retrospective study investigates the success of subcutaneous and intravenous tocilizumab (TCZ) for the treatment of uveitis. Overall, among those with 12-month follow-up, 74.0% of patients achieved treatment success at 1 year (SQ 77.8% and IV 72.2%).
科研通智能强力驱动
Strongly Powered by AbleSci AI
JY
寻道图强
lin
Cloud
CipherSage
穆紫
美好乐松
凤凰
hzc
黑白
脑洞疼
Simon
结实的寄柔
可爱的函函
科目三
Owen
星辰大海
只谈风月
霉小欧
温暖的盼山
皖公网安备34019202002308
